Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.15
Bid: 28.00
Ask: 28.30
Change: -0.45 (-1.57%)
Spread: 0.30 (1.071%)
Open: 28.75
High: 28.75
Low: 28.15
Prev. Close: 28.60
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - hVIVO Plc

10 Dec 2019 14:34



Form 8.3 - hVIVO Plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Jupiter Asset Management Ltd
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereehVIVO plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held: For an opening position disclosure, state the latest practicable date prior to the disclosure9th December 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 5p Ordinary
InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:9,238,69611.09  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:9,238,69611.09  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:None
Details, including nature of the rights concerned and relevant percentages:None

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
NONE   

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
NONE    

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
NONE       

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
NONE   

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
NONE   

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:10th December 2019
Contact name:David Warman
Telephone number:0203 817 1392

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
3rd Oct 20199:51 amRNSDirector's Dealings
2nd Oct 20195:03 pmRNSExercise of Share Options
27th Sep 20197:00 amRNShVIVO to present at ERS International Congress
19th Sep 20197:00 amRNSInterim Results 2019
23rd Aug 20197:00 amRNSNotice of Interim Results
6th Aug 20197:00 amRNSSuccessful RSV Challenge Study in Older Adults
31st Jul 20197:00 amRNSPhase 1 clinical trial of AGS-v PLUS
31st Jul 20197:00 amRNSFinance Director
25th Jul 20193:15 pmRNSExercise of Share Options
25th Jul 20193:10 pmRNSExercise of Share Options
16th Jul 20197:00 amRNSExercise of Share Options
9th Jul 20194:00 pmRNSHolding(s) in Company
9th Jul 201911:00 amRNSHolding(s) in Company
2nd Jul 20191:45 pmRNSDirector's Dealings
26th Jun 20194:10 pmRNSExercise of Share Options
17th Jun 20197:00 amRNSRSV Challenge Model Delivers Positive Results
14th Jun 201912:00 pmRNSExercise of Share Options
31st May 201912:00 pmRNSResult of AGM
21st May 20197:00 amRNSExercise of Share Options
26th Apr 20199:56 amRNS2018 Annual Report and Financial Statements
11th Apr 20197:00 amRNSPreliminary Results 2018
1st Apr 20191:21 pmRNSDirector's Dealings
29th Mar 20197:00 amRNShVIVO and Imutex to present at IVW 2019
21st Mar 201910:34 amRNSExercise of Share Options
8th Mar 20197:00 amRNSNotice of Preliminary Results
30th Jan 20199:55 amRNSHolding(s) in Company
24th Jan 201910:12 amRNSShare Incentive Plan and PDMR Dealings
10th Jan 20197:00 amRNSPositive data for Phase IIb FLU-v challenge study
4th Jan 20194:00 pmRNSDirector's Dealings
4th Jan 201910:02 amRNSAward of Share Options
2nd Jan 20197:00 amRNSDirectorate Change
20th Nov 20187:00 amRNSExercise of Share Options
31st Oct 20187:00 amRNSPartial preliminary results for NIH study of AGS-v
8th Oct 20182:00 pmRNSDirector's Dealings
8th Oct 20187:02 amRNSTwo new contracts for RSV human challenge studies
8th Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSNotification of Major Holdings
28th Sep 201811:00 amRNSNotification of Major Holdings
20th Sep 20187:00 amRNSHalf-year Report
18th Sep 20187:00 amRNSExercise of Share Options
10th Sep 20187:00 amRNSNotification of Major Interest in Shares
29th Aug 20182:00 pmRNSNotification of Major Interest in Shares
29th Aug 20187:00 amRNSNotification of Major Interest in Shares
21st Aug 201811:00 amRNSExercise of Share Options
20th Aug 20187:00 amRNSNotification of Major Interest in Shares
16th Aug 20187:00 amRNSNotice of Interim Results
13th Aug 20187:00 amRNSAward of Share Options
10th Aug 20187:00 amRNSDirector's Dealings
10th Aug 20187:00 amRNSExercise of Share Options
27th Jul 20187:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.